EMX vs. PFE
Compare and contrast key facts about EMX Royalty Corporation (EMX) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EMX or PFE.
Correlation
The correlation between EMX and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
EMX vs. PFE - Performance Comparison
Key characteristics
EMX:
0.38
PFE:
-0.66
EMX:
1.01
PFE:
-0.64
EMX:
1.11
PFE:
0.93
EMX:
0.32
PFE:
-0.22
EMX:
1.24
PFE:
-0.99
EMX:
14.56%
PFE:
13.28%
EMX:
36.50%
PFE:
23.84%
EMX:
-90.61%
PFE:
-58.96%
EMX:
-42.02%
PFE:
-56.84%
Fundamentals
EMX:
$232.59M
PFE:
$134.92B
EMX:
-$0.03
PFE:
$1.41
EMX:
0.00
PFE:
0.61
EMX:
8.46
PFE:
2.17
EMX:
2.01
PFE:
1.56
EMX:
$18.20M
PFE:
$62.46B
EMX:
$12.44M
PFE:
$42.09B
EMX:
$9.81M
PFE:
$16.71B
Returns By Period
In the year-to-date period, EMX achieves a 24.86% return, which is significantly higher than PFE's -13.00% return. Over the past 10 years, EMX has outperformed PFE with an annualized return of 14.07%, while PFE has yielded a comparatively lower 0.49% annualized return.
EMX
24.86%
15.51%
20.00%
13.68%
3.61%
14.07%
PFE
-13.00%
0.96%
-13.62%
-15.65%
-4.53%
0.49%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
EMX vs. PFE — Risk-Adjusted Performance Rank
EMX
PFE
EMX vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for EMX Royalty Corporation (EMX) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
EMX vs. PFE - Dividend Comparison
EMX has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 7.63%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EMX EMX Royalty Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 7.63% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% | 3.34% |
Drawdowns
EMX vs. PFE - Drawdown Comparison
The maximum EMX drawdown since its inception was -90.61%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for EMX and PFE. For additional features, visit the drawdowns tool.
Volatility
EMX vs. PFE - Volatility Comparison
EMX Royalty Corporation (EMX) has a higher volatility of 14.85% compared to Pfizer Inc. (PFE) at 9.05%. This indicates that EMX's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
EMX vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between EMX Royalty Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EMX vs. PFE - Profitability Comparison
EMX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, EMX Royalty Corporation reported a gross profit of 6.30M and revenue of 6.93M. Therefore, the gross margin over that period was 90.9%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
EMX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, EMX Royalty Corporation reported an operating income of 3.39M and revenue of 6.93M, resulting in an operating margin of 48.9%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
EMX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, EMX Royalty Corporation reported a net income of 1.77M and revenue of 6.93M, resulting in a net margin of 25.5%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.